Adma Biologics Inc. (ADMA)
NASDAQ (NMS) NASDAQ (NMS) Primary 
Best Momentum Stocks to Buy for March 12th
ADMA, RELY and HSY made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on March 12th, 2026.
New Strong Buy Stocks for March 12th
AEO, RELY, ADMA, HSY and HTBK have been added to the Zacks Rank #1 (Strong Buy) List on March 12th, 2026.
Adma Biologics (ADMA) Upgraded to Strong Buy: Here's Why
Adma Biologics (ADMA) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Wall Street Analysts Think Adma Biologics (ADMA) Is a Good Investment: Is It?
Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm employed (or sell-side) analysts often affect a stock's price, do they really matter?
ADMA Q4 EPS Up 14% Y/Y, Revenues Gain From Strong Asceniv Performance
ADMA posts 18% Q4 revenue growth as Asceniv drives record 2025 sales, with 2026 revenues seen topping $635M and margins set to expand.
ADMA Biologics, Inc. (ADMA) Q4 2025 Earnings Call Transcript
ADMA Biologics, Inc. (ADMA) Q4 2025 Earnings Call Transcript
Adma Biologics (ADMA) Ascends While Market Falls: Some Facts to Note
Adma Biologics (ADMA) closed the most recent trading day at $16.32, moving +2.06% from the previous trading session.
Adma Biologics (ADMA) Registers a Bigger Fall Than the Market: Important Facts to Note
Adma Biologics (ADMA) closed at $15.59 in the latest trading session, marking a -4.24% move from the prior day.
Adma Biologics (ADMA) Exceeds Market Returns: Some Facts to Consider
In the closing of the recent trading day, Adma Biologics (ADMA) stood at $17.5, denoting a +1.16% move from the preceding trading day.
Is It Worth Investing in Adma Biologics (ADMA) Based on Wall Street's Bullish Views?
When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts often influence a stock's price, but are they really important?
ADMA Gains 13.8% in Three Months: More Upside Potential for 2026?
ADMA shares rose 13.8% over three months as demand for Asceniv surged, driving higher 2026 revenues and EBITDA targets amid margin expansion.
Adma Biologics (ADMA) Increases Despite Market Slip: Here's What You Need to Know
Adma Biologics (ADMA) concluded the recent trading session at $17.59, signifying a +1.62% move from its prior day's close.
